CLASS II ANTIGEN PRESENTATION VIA CHAPERONE MEDIATED AUTOPHAGY
CLASS II ANTIGEN PRESENTATION VIA CHAPERONE MEDIATED AUTOPHAGY
批准号:
7983952
负责人:
Janice S Blum
金额:
$34.65万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2015-04-30
关键词:
Antigen PresentationAntigensAutoantigensAutoimmunityAutophagocytosisB-LymphocytesBindingBiochemicalCD4 Positive T LymphocytesCell NucleusCell Surface ProteinsCell surfaceCellsCellular StressClientComplexCytoplasmEndosomesEpitopesEquilibriumEventFamilyFamily memberGenesGoalsHeat shock proteinsHeat-Shock Proteins 90Histocompatibility Antigens Class IHistocompatibility Antigens Class IIImmuneImmune systemImmunityIndividualLAMP-2LeadLigandsLysosomesMaintenanceMalignant NeoplasmsMediatingMembrane ProteinsMembrane Transport ProteinsMolecularMolecular ChaperonesNuclearOncogenic VirusesOrganellesPathway interactionsPeptide HydrolasesPeptide/MHC ComplexPeptidesPhagosomesProcessProtein FamilyProtein IsoformsProteinsProteolysisRoleRouteSamplingSelf ToleranceShapesSorting - Cell MovementSourceT cell responseTestingTissuesTumor AntigensViralWorkantigen processingdesigninsightmelanomaneoplastic cellnovelnovel strategiespathogenpublic health relevanceresearch studytumortumor growthvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Peptides derived from foreign and self antigens are presented in the context of MHC class II molecules for recognition by CD4+ T cells. Class II molecules transit the endosomal network of cells, acquiring peptides from exogenous antigens as well as endogenous cell surface and endosomal proteins. Surprisingly, epitopes from cytoplasmic antigens also are presented by class II molecules. The overall goal of this proposal is to understand the mechanisms regulating class II cytoplasmic Ag presentation, and to identify new means to modulate immunity to self and tumor Ags. With subversion of class I presentation by tumors and viruses, exploiting novel pathways for cytoplasmic Ag presentation remains important. Targeting specific cytoplasmic Ags for class II presentation offers a unique approach to promote immune recognition and overcome such immune evasion. The current proposal focuses on a selective pathway, chaperone mediated autophagy (CMA) which facilitates class II cytoplasmic antigen presentation. We propose that cytoplasmic antigens are selectively targeted by cytosolic chaperones for proteolysis during CMA. The resulting peptides may then be chaperoned to a membrane transporter, LAMP-2A for translocation into the endosomal network for class II presentation. Studies are proposed to define the importance of chaperones, HSC70 and HSP90 in guiding cytoplasmic antigens for processing and translocation into organelles for class II presentation. Multiple isoforms of the LAMP-2 gene are expressed in B cells and melanomas, potentially regulating class II cytoplasmic antigen presentation by autophagy. Studies are proposed to elucidate the role of individual LAMP- 2 isoforms in class II presentation pathways. This project will offer critical insights into the molecular events and essential co-factors for CMA which faciliate class II access to cytoplasmic antigens for immune recognition. Notably, autophagy pathways are often up-regulated in tumor cells to promote tumor growth and survivial. Such changes in cellular autophagy pathways may enhance tumor antigen recognition. Studies in this project will examine the importance of distinct autophagy pathways in cytoplasmic antigen presentation by melanomas. This work also has relevance to our understanding of autoimmunity to self antigens and tolerance induction. Exploiting the selectivity of the CMA pathway may also offer opportunities for novel approaches to vaccine development.
PUBLIC HEALTH RELEVANCE: This work has relevance to our general understanding of how the immune system distinguishes self and foreign molecules. The project has implications for cancer as autophagy is often up-regulated in tumors, and this could be exploited to promote immune recognition of tumor cells. These studies may also be important in understanding autoimmunty, and lead to new approaches for vaccine development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Short-term training program in biomedical sciences
-
批准号:8214417
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2012
-
负责人:Janice S Blum
-
依托单位:
Short-Term Training Program In Biomedical Sciences
-
批准号:8620706
-
项目类别:
-
资助金额:$17.29万
-
财政年份:2012
-
负责人:Janice S Blum
-
依托单位:
Short-term training program in biomedical sciences
-
批准号:8433314
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2012
-
负责人:Janice S Blum
-
依托单位:
CLASS II ANTIGEN PRESENTATION VIA CHAPERONE MEDIATED AUTOPHAGY
-
批准号:8260287
-
项目类别:
-
资助金额:$34.3万
-
财政年份:2010
-
负责人:Janice S Blum
-
依托单位:
CLASS II ANTIGEN PRESENTATION VIA CHAPERONE MEDIATED AUTOPHAGY
-
批准号:8066363
-
项目类别:
-
资助金额:$34.3万
-
财政年份:2010
-
负责人:Janice S Blum
-
依托单位:
CLASS II ANTIGEN PRESENTATION VIA CHAPERONE MEDIATED AUTOPHAGY
-
批准号:8459995
-
项目类别:
-
资助金额:$37.83万
-
财政年份:2010
-
负责人:Janice S Blum
-
依托单位:
CLASS II ANTIGEN PRESENTATION VIA CHAPERONE MEDIATED AUTOPHAGY
-
批准号:8651856
-
项目类别:
-
资助金额:$35.75万
-
财政年份:2010
-
负责人:Janice S Blum
-
依托单位:
CLASS II ANTIGEN PRESENTATION VIA CHAPERONE MEDIATED AUTOPHAGY
-
批准号:8498672
-
项目类别:
-
资助金额:$4.5万
-
财政年份:2010
-
负责人:Janice S Blum
-
依托单位:
Role of IL-17-secreting T cells in anti-viral immunity
-
批准号:7392880
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2007
-
负责人:Janice S Blum
-
依托单位:
Role of IL-17-secreting T cells in anti-viral immunity
-
批准号:7478742
-
项目类别:
-
资助金额:$22.04万
-
财政年份:2007
-
负责人:Janice S Blum
-
依托单位:
Immunology and Infectious Diseases
-
批准号:7867878
-
项目类别:
-
资助金额:$27.04万
-
财政年份:2004
-
负责人:Janice S Blum
-
依托单位:
Immunology and Infectious Diseases
-
批准号:8447517
-
项目类别:
-
资助金额:$26.38万
-
财政年份:2004
-
负责人:Janice S Blum
-
依托单位:
Immunology and Infectious Diseases
-
批准号:6943659
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2004
-
负责人:Janice S Blum
-
依托单位:
Immunology and Infectious Diseases
-
批准号:6801309
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2004
-
负责人:Janice S Blum
-
依托单位:
Immunology and Infectious Diseases
-
批准号:7440268
-
项目类别:
-
资助金额:$29.63万
-
财政年份:2004
-
负责人:Janice S Blum
-
依托单位:
Immunology and Infectious Diseases
-
批准号:8740900
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2004
-
负责人:Janice S Blum
-
依托单位:
Immunology and Infectious Diseases
-
批准号:7096628
-
项目类别:
-
资助金额:$29.18万
-
财政年份:2004
-
负责人:Janice S Blum
-
依托单位:
Immunology and Infectious Diseases
-
批准号:7245908
-
项目类别:
-
资助金额:$29.63万
-
财政年份:2004
-
负责人:Janice S Blum
-
依托单位:
Immunology and Infectious Diseases
-
批准号:7693958
-
项目类别:
-
资助金额:$28.53万
-
财政年份:2004
-
负责人:Janice S Blum
-
依托单位:
Immunology and Infectious Diseases
-
批准号:8269004
-
项目类别:
-
资助金额:$24.05万
-
财政年份:2004
-
负责人:Janice S Blum
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: